NORTHWEST BIOTHERAPEUTICS INC (NWBO) › Cash & EquivalentsNORTHWEST BIOTHERAPEUTICS INC (NWBO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.1996: $02009: $65.0K2010: $153.0K2011: $24.0K2012: $7.35M2013: $18.50M2014: $13.39M2015: $21.81M2016: $6.87M2017: $117.0K2018: $22.22M2019: $372.0K2020: $9.98M2021: $15.17M2022: $6.96M2023: $2.13M2024: $2.17M2025: $3.04M$3.04M1996Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$3.04M+39.8%2024$2.17M+2.3%2023$2.13M-69.5%2022$6.96M-54.1%2021$15.17M+51.9%2020$9.98M+2583.6%2019$372.0K-98.3%2018$22.22M+18894.9%2017$117.0K-98.3%2016$6.87M-68.5%2015$21.81M+62.9%2014$13.39M-27.6%2013$18.50M+151.8%2012$7.35M+30508.3%2011$24.0K-84.3%2010$153.0K+135.4%2009$65.0K—1996$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share